TITLE

Academic athletes

AUTHOR(S)
Magnus, Ben
PUB. DATE
April 2008
SOURCE
CMAJ: Canadian Medical Association Journal;4/8/2008, Vol. 178 Issue 8, p989
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses the healthy people's increasing usage of brain boosting prescription drugs. It states that the British Medical Association is getting concerned about the healthy people's progressive use of brain boosting prescription drugs. The Association's medical ethics committee contends that greater use of cognitive enhancements requires that society look at the issue of whether and how to regulate drugs aimed at healthy people. The committee notifies widespread, unlawful use of brain boosters like modafinil and methylphenidate in Great Britain is both impending and inevitable. Modafinil is prescribed to treat narcolepsy, but this stimulant is also popular to increase alertness in truckers, athletes, poker players and students.
ACCESSION #
31495267

 

Related Articles

  • Armodafinil. Garnock-Jones, Karly P.; Dhillon, Sohita; Scott, Lesley J. // CNS Drugs;2009, Vol. 23 Issue 9, p793 

    â–´ Armodafinil is the R-enantiomer of modafinil, a wake-promoting agent, that primarily affects areas of the brain involved in controlling wakefulness. â–´ Once-daily armodafinil was effective in improving wakefulness in adult patients with excessive sleepiness associated with...

  • EEG-mapping differences between narcolepsy patients and controls and subsequent double-blind, placebo-controlled studies with modafinil. Saletu, Michael T.; Anderer, Peter; Saletu-Zyhlarz, Gerda M.; Mandl, Magdalena; Arnold, Oliver; Nosiska, Dorothea; Zeitlhofer, Josef; Saletu, Bernd // European Archives of Psychiatry & Clinical Neuroscience;2005, Vol. 255 Issue 1, p20 

    The aim of the present study was to investigate the role of EEG mapping as an objective and quantitative measure of vigilance in untreated and modafinil-treated narcoleptics, and compare it with the conventional neurophysiological method of the Multiple Sleep Latency Test (MSLT) and the...

  • Modafinil : A Review of its Pharmacology and Clinical Efficacy in the Management of Narcolepsy. McClellan, K.J.; Spencer, C.M. // CNS Drugs;1998, Vol. 9 Issue 4, p311 

    Synopsis: Modafinil promotes wakefulness through an as yet unknown mechanism of action. It significantly increases daytime sleep latency and reduces excessive daytime sleepiness (EDS) compared with placebo in patients with narcolepsy. However, the drug does not suppress cataplexy....

  • Novel Drug May Help Patients With Narcolepsy Maintain Wakefulness. Greb, Erik // Neurology Reviews;Sep2014, Vol. 22 Issue 9, p10 

    The article discusses a research study which suggests the efficacy of the experimental drug JZP-110 in treating patients with narcolepsy and excessive daytime sleepiness and in maintaining wakefulness, presented at the 28th Annual Meeting of the Associated Professional Sleep Societies. Data...

  • A double-blind, placebo-controlled investigation of the efficacy of modafinil for sustaining the alertness and performance of aviators: a helicopter simulator study. Caldwell Jr, John A.; Caldwell, J. Lynn; Smythe III, Nicholas K.; Hall, Kecia K. // Psychopharmacology;2000, Vol. 150 Issue 3, p272 

    Abstract Rationale: In 1998, the FDA approved modafinil for treating excessive daytime sleepiness in narcoleptics, and this has raised questions about the appropriateness of this compound for enhancing alertness in sleep-deprived controls. This study explored the efficacy of modafinil for...

  • Association members unhappy with MBA's services.  // British Medical Journal (Clinical Research Edition);4/20/1985, Vol. 290 Issue 6476, p1228 

    Reports the dissatisfaction of student members on the services offered by the British Medical Association (BMA) in Great Britain. Benefits offered by BMA; Proposals for an annual representative meeting; Enumeration of shortfalls on medical students' grants.

  • β-Hydroxy-β-Methylbutyrate (HMB) Supplementation Does Not Affect Charges in Strength or Body Composition During Resistance Training in Trained Men. Slater, Gary; Jenkins, David; Logan, Peter; Lee, Hamilton; Vukovich, Matthew; Rathmacher, John A.; Hahn, Allan G. // International Journal of Sport Nutrition & Exercise Metabolism;Sep2001, Vol. 11 Issue 3, p384 

    Presents a study which evaluated the effects of oral β-hydroxy-β-methylbutyrate (HMB) supplementation on training responses in resistance-trained male athletes. Measurement of total body mass; Urine collection and analysis; Body composition measurements before and after weeks of placebo,...

  • DoH under fire over generic switching.  // GP: General Practitioner;4/9/2010, p16 

    The article reports that the British Medical Association (BMA), the Pharmaceutical Services Negotiating Committee (PSNC) and epilepsy and stroke charities in Great Britain has criticised the Department of Health (DoH) plans to allow pharmacists in England to switch drugs prescribed by brand for...

  • High drug costs threaten PCGs. Ward, Seamus // Public Finance;01/07/2000, p11 

    Reports that huge price rises in generic drugs and their recent lack of availability threaten to the undermine the success of Primary Care Groups in Great Britain. Concerns expressed by the British Medical Association; Rationale for the preference for generic prescribing; Budgetary effects of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics